2015
DOI: 10.2147/ott.s92758
|View full text |Cite
|
Sign up to set email alerts
|

MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1

Abstract: MiR-29c is frequently dysregulated in many cancers; however, the roles of miR-29c in pancreatic cancer (PC) and underlying mechanisms remain poorly understood. In this study, we investigated the role of miR-29c in PC. Using quantitative real-time polymerase chain reaction, we demonstrated that miR-29c was frequently downregulated in clinical PC tissues and cell lines. Overexpression of miR-29c significantly inhibited the proliferation, migration, and invasion of PC cells in vitro, which demonstrated that miR-2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
17
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(19 citation statements)
references
References 34 publications
1
17
0
1
Order By: Relevance
“…Thus, miRNAs have the potential to serve as novel biomarkers for cancer diagnosis and prognosis prediction, as they remain largely intact. Several miRNAs have been reported to serve vital roles in the tumorigenesis and prognosis of PAAD ( 16 21 ). However, the associations between other miRNAs and the survival of patients with PAAD remains unclear.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, miRNAs have the potential to serve as novel biomarkers for cancer diagnosis and prognosis prediction, as they remain largely intact. Several miRNAs have been reported to serve vital roles in the tumorigenesis and prognosis of PAAD ( 16 21 ). However, the associations between other miRNAs and the survival of patients with PAAD remains unclear.…”
Section: Introductionmentioning
confidence: 99%
“…MiR-29c plays the role as tumor suppressor in several kinds of tumors. MiR-29c was shown to inhibit cell growth, cell migration and invasion in pancreatic cancer by targeting ITGB1 [ 5 ]. In bladder cancer, miR-29c overexpression inhibited cell growth, suppressed cell migration and resulted in an accumulation of cells in the G1 phase during the cell cycle through the target gene CDK6 [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Targeting TKT has been demonstrated to lead to increased oxidative stress, causing increased sensitivity of cancer cells to therapeutic treatments, including Sorafenib ( 29 ). ATP binding cassette subfamily C member 1 ( 30 ), integrin subunit β1 (ITGB1) ( 31 , 32 ) and aldo-keto reductase family 1 member B ( 33 , 34 ) have been reported to be involved in chemoresistance/radioresistance and cancer metastasis. P21-activated kinase 2 ( 35 ), G protein nucleolar 3 ( 36 ), nucleophosmin ( 37 ) and pericentriolar material 1 ( 38 ) have been associated with metastatic characteristics in various types of cancer.…”
Section: Resultsmentioning
confidence: 99%